Metabotropic Glutamate 5 Receptor Antagonism Is Associated with Antidepressant-Like Effects in Mice
Authors:
- Xia LiXLXia Li
- Anne B. NeedANAnne B. Need
- Melvyn BaezMBMelvyn Baez
- Jeffrey M. WitkinJWJeffrey M. Witkin
- 1 October 2006
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 319 (1) , 254-259
Abstract
Antidepressant-like effects of metabotropic glutamate (mGlu)5 receptor antagonists have been reported previously. We now provide definitive identification of mGlu5 receptors as a target for these effects through the combined use of selective antagonists and mice with targeted deletion of the mGlu5 protein. In these experiments, the mGlu5 receptor antagonists 2-methyl-6-(phenylethynyl)-pyridine (MPEP) and the more selective and metabolically stable analog 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP) decreased immobility in the mouse forced swim test, a test predictive of antidepressant efficacy in humans. mGlu5 receptor knockout mice had a phenotype in the forced swim test that was congruent with the effects of receptor blockade; mGlu5 receptor knockout mice were significantly less immobile than their wild-type counterparts. Consistent with mGlu5 receptor mediation of the antidepressant-like effects of MPEP, the effects of MPEP were not observed in mGlu5 receptor knockout mice, whereas comparable effects of the tricyclic antidepressant imiprimine remained active in the mutant mice. MPEP and imiprimine resulted in a synergistic antidepressant-like effect in the forced swim test. The drug interaction was not likely because of increased levels of drugs in the brain, suggesting a pharmacodynamic interaction of mGlu5 and monoaminergic systems in this effect. Thus, the present findings substantiate the hypothesis that mGlu5 receptor antagonism is associated with antidepressant-like effects. This mechanism may not only provide a novel approach to the therapeutic management of depressive disorders but also may be useful in the augmentation of effects of traditional antidepressant agents.Keywords
This publication has 33 references indexed in Scilit:
- Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonistPharmacology Biochemistry and Behavior, 2005
- Metabotropic glutamate receptors as novel targets for anxiety and stress disordersNature Reviews Drug Discovery, 2005
- Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABAA signalingNeuropharmacology, 2004
- 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3′-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activityBioorganic & Medicinal Chemistry Letters, 2004
- mGlu5 receptor antagonists: A novel class of anxiolytics?Drug News & Perspectives, 2004
- Glutamate and DepressionAnnals of the New York Academy of Sciences, 2003
- Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disordersBehavioural Pharmacology, 2003
- Metabotropic Glutamate Subtype 5 Receptors Modulate Locomotor Activity and Sensorimotor Gating in RodentsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant miceNature Neuroscience, 2001
- Current perspectives on the development of non-biogenic amine-based antidepressantsPharmacological Research, 2001